Michael Powell, PhD, is a Senior Scientist at AstraZeneca specializing in translational immunology, with over 10 years of expertise in molecular science and clinical research. Previously serving as a postdoctoral researcher at both The Ohio State University and Emory University School of Medicine, they have focused on T helper cell differentiation and vaccine efficacy, resulting in more than 20 peer-reviewed publications. Michael obtained a PhD in Immunology from Virginia Tech after earning a Bachelor of Science in Bioengineering and Biomedical Engineering from the University of Maryland.
This person is not in the org chart
This person is not in any teams
This person is not in any offices